Atlas Trials

Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects

Clinical trial NCT01053520 · COMPLETED

Trial details

NCT number
NCT01053520
Sponsor
Abbott
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Female Subjects
Start date
2009-10-01
Primary completion
2009-12-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.